drugset / Trial / NCT03393715

Effect of Morning Versus Evening Perindopril on Blood Pressure Control in People With Type 2 Diabetes

NCT03393715

RandomizedCrossoverOpen-labelTreatment

Summary

We assessed the influence of time of administration of ACE inhibitors on circadian blood pressure control in sub Saharan type 2 diabetes patients with stage 1 hypertension over 56 days as first line treatment.

Timeline

Start
2016-02
Primary completion
2016-07
Completion
2016-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Perindopril Small molecule 10 mg Oral